SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-13-435407
Filing Date
2013-11-08
Accepted
2013-11-08 16:56:07
Documents
4
Group Members
GEORGE SOROSROBERT SOROS

Document Format Files

Seq Description Document Type Size
1 SC 13G d625818dsc13g.htm SC 13G 75886
2 EX A d625818dex99a.htm EX-99.A 6086
3 EX B d625818dex99b.htm EX-99.B 4515
4 EX C d625818dex99c.htm EX-99.C 4093
  Complete submission text file 0001193125-13-435407.txt   92260
Mailing Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 (212) 872-1054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Subject) CIK: 0001195116 (see all company filings)

IRS No.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83157 | Film No.: 131205504
SIC: 2834 Pharmaceutical Preparations